Silk Road Medical, Inc (SILK)

Etorro trading 970x250
Silk Road Medical, Inc (SILK) Logo

About Silk Road Medical, Inc

Silk Road Medical, Inc. operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization. Its products includes ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and initiate temporary blood flow reversal; ENROUTE Transcarotid Stent System, a self-expanding, self-tapering stent; ENHANCE Transcarotid Peripheral Access Kit for use in gaining initial access to the common carotid artery; and ENROUTE 0.014 Guidewire for navigating and crossing the target lesion for delivery of interventional devices. The company was incorporated in 2007 and is headquartered in Sunnyvale, California. Address: 1213 Innsbruck Drive, Sunnyvale, CA, United States, 94089

Silk Road Medical, Inc News and around…

Latest news about Silk Road Medical, Inc (SILK) common stock and company :

Is It Too Late To Consider Buying Silk Road Medical, Inc (NASDAQ:SILK)?
25 Nov, 2021 Yahoo! Finance

Silk Road Medical, Inc ( NASDAQ:SILK ), is not the largest company out there, but it saw significant share price...

Notable Silk Road Medical Insider Trades $940K In Company Stock
16 Nov, 2021 Yahoo! Finance

Erica Rogers, CEO at Silk Road Medical (NASDAQ:SILK), made a large buy and sell of company shares on November 11, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission states that Erica Rogers exercised options to purchase 15,738 Silk Road Medical shares at prices ranging from $1.46 to $1.60 per share for a total of $24,377 on November 11. They then sold their shares on the same day in the open market. They sold at prices ranging from $50.

Silk Road Medical to Present at the Piper Sandler 33rd Annual Virtual Healthcare Conference
10 Nov, 2021 Yahoo! Finance

SUNNYVALE, Calif., Nov. 10, 2021 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced the company will be participating in a fireside chat at the upcoming Piper Sandler 33rd Annual Virtual Healthcare Conference. A recording of the presentation will be available beginning on Monday, November 22, 2021 at 10:00 a.m. Eastern Time. Interested parties may access the presentation on the “Investors” secti

SILK Crosses Below Key Moving Average Level
10 Nov, 2021 FinancialContent

In trading on Wednesday, shares of Silk Road Medical Inc (SILK) crossed below their 200 day moving average of $53.06, changing hands as low as $52.20 per share. Silk Road Medical Inc shares are currently trading down about 8.6% on the day..

Silk Road Medical, inc (SILK) Q3 2021 Earnings Call Transcript
10 Nov, 2021 FinancialContent

SILK earnings call for the period ending September 30, 2021.

Silk Road Medical (SILK) Reports Q3 Loss, Lags Revenue Estimates
09 Nov, 2021 Yahoo! Finance

Silk Road Medical (SILK) delivered earnings and revenue surprises of -29.03% and -5.09%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

Silk Road Medical Reports Third Quarter 2021 Financial Results
09 Nov, 2021 Yahoo! Finance

SUNNYVALE, Calif., Nov. 09, 2021 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today reported financial results for the quarter ended September 30, 2021. “I am incredibly proud of our team for continuing to drive TCAR adoption forward against the headwinds of the pandemic,” said Erica Rogers, President and Chief Executive Officer of Silk Road Medical. “We are investing confidently in the people and program

The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data
09 Nov, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck Gets Antitrust Nod For ...

The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More
08 Nov, 2021 FinancialContent

Biotech stocks reversed course and closed the week ended Nov. 5 lower, squandering the gains notched early in the week. What was good ...

Chief Commercial Officer Of Silk Road Medical Trades $395K In Company Stock
03 Nov, 2021 Yahoo! Finance

Andrew Davis, Chief Commercial Officer at Silk Road Medical (NASDAQ:SILK), made a large buy and sell of company shares on November 1, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission states that Andrew Davis exercised options to purchase 4,805 Silk Road Medical shares at prices ranging from $4.73 to $52.07 per share for a total of $101,343 on November 1. They then sold their shares on the same day in the open market. They sold at a pr

Silk Road Medical to Present at the Stifel 2021 Virtual Healthcare Conference
02 Nov, 2021 Yahoo! Finance

SUNNYVALE, Calif., Nov. 02, 2021 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced the company will be participating in a fireside chat at the upcoming Stifel 2021 Virtual Healthcare Conference. Silk Road Medical’s management is scheduled to present on Tuesday, November 16, 2021 at 1:20 p.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation on the “Inve

Will Silk Road Medical (SILK) Report Negative Earnings Next Week? What You Should Know
02 Nov, 2021 Yahoo! Finance

Silk Road Medical (SILK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

CFO Of Silk Road Medical Trades $710K In Company Stock
01 Nov, 2021 Yahoo! Finance

Lucas Buchanan,CFO at Silk Road Medical (NASDAQ:SILK), made a large buy and sell of company shares on October 27, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission states that Lucas Buchanan exercised options to purchase 10,000 Silk Road Medical shares at a price of $12.15 per share for a total of $121,500 on October 27. They then sold their shares on the same day in the open market. They sold at a price of $59.39 to raise a total of $

Silk Road Medical Getting Closer To Key Technical Measure
29 Oct, 2021 FinancialContent

Silk Road Medical shows improving price performance, earning an upgrade to its IBD Relative Strength Rating

Silk Road Medical to Report Third Quarter 2021 Financial Results on November 9, 2021
21 Oct, 2021 Yahoo! Finance

SUNNYVALE, Calif., Oct. 21, 2021 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced it will report financial results for the third quarter 2021 after market close on Tuesday, November 9, 2021. Company management will host a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. Investors interested in listening to the conference call may do so by dialing (844

President And CEO Of Silk Road Medical Trades $630K In Company Stock
13 Oct, 2021 Yahoo! Finance

Erica Rogers, President And CEO at Silk Road Medical (NASDAQ:SILK), made a large buy and sell of company shares on October 11, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission states that Erica Rogers exercised options to purchase 11,000 Silk Road Medical shares at a price of $1.60 per share for a total of $17,600 on October 11. They then sold their shares on the same day in the open market. They sold at a price of $55.73 to raise a t

Loss-making Silk Road Medical (NASDAQ:SILK) has seen earnings and shareholder returns follow the same downward trajectory over past -15%
11 Oct, 2021 Yahoo! Finance

Silk Road Medical, Inc ( NASDAQ:SILK ) shareholders should be happy to see the share price up 21% in the last quarter...

Chief Commercial Officer Of Silk Road Medical Trades $370K In Company Stock
06 Oct, 2021 Yahoo! Finance

Andrew Davis, Chief Commercial Officer at Silk Road Medical (NASDAQ:SILK), made a large buy and sell of company shares on October 1, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission states that Andrew Davis exercised options to purchase 6,324 Silk Road Medical shares at a price of $4.73 per share for a total of $29,913 on October 1. They then sold their shares on the same day in the open market. They sold at a price of $53.90 to raise

Notable Silk Road Medical Insider Trades $670K In Company Stock
30 Sep, 2021 Yahoo! Finance

Lucas Buchanan, COO & CFO at Silk Road Medical (NASDAQ:SILK), made a large buy and sell of company shares on September 28, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission states that Lucas Buchanan exercised options to purchase 10,000 Silk Road Medical shares at a price of $12.15 per share for a total of $121,500 on September 28. They then sold their shares on the same day in the open market. They sold at a price of $54.86 to raise a

Is Silk Road Medical (SILK) a Great Growth Stock?
30 Sep, 2021 Yahoo! Finance

If you are looking for a fast-growing stock that is still seeing plenty of opportunities on the horizon, make sure to consider Silk Road Medical (SILK).

Silk Road Medical (SILK) Upgraded to Buy: Here's Why
29 Sep, 2021 Yahoo! Finance

Silk Road Medical (SILK) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Implied IEHS Analyst Target Price: $48
28 Sep, 2021 FinancialContent

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the iShares Evolved US.

President And CEO Of Silk Road Medical Trades $648.17 Thousand In Company Stock
15 Sep, 2021 Yahoo! Finance

Erica Rogers, President And CEO at Silk Road Medical (NASDAQ:SILK), made a large buy and sell of company shares on September 13, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission reports that on September 13, Erica Rogers bought 11,000 Silk Road Medical shares at a price of $1.60 per share, for a total of $17,600. They then sold their shares on the same day in the open market at a price of $57.32 to raise a total of $630,565 from the s

Silk Road Medical Scores Relative Strength Rating Upgrade; Hits Key Threshold
09 Sep, 2021 FinancialContent

Silk Road Medical sees its Relative Strength Rating reach the 80-plus level.

Stocks Flashing Renewed Technical Strength: Silk Road Medical
07 Sep, 2021 FinancialContent

Silk Road Medical sees its Relative Strength Rating hit the 80-plus level.

Silk Road Medical Scores Relative Strength Rating Upgrade; Hits Key Benchmark
03 Sep, 2021 FinancialContent

Silk Road Medical shows rising price performance, earning an upgrade to its IBD Relative Strength Rating from 66 to 80.

Silk Road Medical to Present at the Morgan Stanley 19th Annual Global Healthcare Conference
01 Sep, 2021 FinancialContent
A Guide to Selecting the Right Bedding Fabric for North American Homes (Source: Bedsure)
26 Aug, 2021 FinancialContent
How The Pieces Add Up: XHE Targets $153
25 Aug, 2021 FinancialContent

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the SPDR— S&P— Health Care Equipment ETF (XHE), we found that the implied analyst target price for the ETF based upon its underlying holdings is $152.52 per unit.

First Ever Analysis of TCAR in Standard Surgical Risk Patients Demonstrates Clinical Benefits in Large Comparative Dataset
18 Aug, 2021 FinancialContent

Silk Road Medical, Inc (SILK) is a NASDAQ Common Stock listed in , ,

970x250